Pavel Dundr

23PUBLICATIONS
66CO-AUTHORS
Foetal development and medicinePredictive and prognostic markersSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 23, 2026
Folate receptor alpha (FRα) expression in tubo-ovarian and endometrial tumors: a study of 923 cases.

Isabela Töltési, Kristýna Němejcová, Michaela Kendall Bártů

|Jan 28, 2026
CTNNB1 mutation represents a recurrent driver molecular alteration in a subset of endometrial stromal tumors.

Pavel Dundr, Eliška Radová, Jan Hojný

|Apr 07, 2025
New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic.

Borek Sehnal, Martin Hruda, Radoslav Matej

|Dec 03, 2024
Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases.

Pavel Dundr, Jiří Dvořák, Michaela Krausová

|Aug 20, 2024
Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer.

Tereza Lanickova, Michal Hensler, Lenka Kasikova

Pageof 4